Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Decitabine

A nucleoside analogue that reduces DNA methylation in tumour cells: approved in the US in 2006 for myelodysplastic syndromes and in Europe in 2012 for acute myeloid leukaemia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?It was born in Czechoslovakia as the 'twin' of azacitidine with one oxygen atom fewer: this small difference means it is built only into DNA, not RNA.

DecitabineGo to the active ingredient →
DecitabineActive ingredientDecitabineCat. No. P-D029-001CAS 2353-33-5
RibalImpurityRibalCat. No. P-D029-064CAS 96761-00-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.